Uro-oncólogos y oncólogos radioterápicos abordan los retos más relevantes del cáncer de próstata para mejorar el diagnóstico.
Armando and Laura were compensated by Astellas and Pfizer to share their story. This was Armando's experience at the time of publication. Please see Important Safety Information below. Are ...
El laboratorio ultima una inversión de 50 millones de euros para trasladar su fábrica de principios activos en China ...
"Teaming up with Universal Cells, part of Astellas, allows us to bring our comprehensive immune cell engineering capabilities to a highly respected, global pharmaceutical leader. We look forward ...
Astellas Pharma Inc. announced that China’s National Medical Products Administration (NMPA) has approved Padcev (enfortumab vedotin) in combination with Keytruda (pembrolizumab) for adult patients ...
Under the agreement, Axcelead DDP will support Astellas’ targeted protein degrader discovery utilizing DegLead TM Platform and contribute to the generation of breakthrough new drug candidate ...
China detains South Korean on suspicion of espionage Worldcategory· October 29, 2024 The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer ...
Cell therapy specialist Mogrify has struck a deal with Japanese drugmaker Astellas to look at ways to deploy regenerative medicine to treat hearing loss caused by factors such as chronic exposure ...
Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback